A calculated choice | Cancer World Archive
External Validation of Adjuvant! Online Breast Cancer Prognosis Tool. Prioritising Recommendations for Improvement | PLOS ONE
PDF) Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria
Should Pfizer's Ibrance give up early-stage breast cancer drug market? < Pharma < Article - KBR
Cancers | Free Full-Text | Post-Neoadjuvant Treatment Strategies for Patients with Early Breast Cancer
Assessment of Risk Recurrence: Adjuvant Online, OncotypeDx & Mammaprint
An investigation into the performance of the Adjuvant! Online prognostic programme in early breast cancer for a cohort of patients in the United Kingdom | British Journal of Cancer
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years - ScienceDirect
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer | NEJM
Deciding About Breast Cancer Chemotherapy
Buy Adjuvant Therapy of Primary Breast Cancer (Recent Results in Cancer Research) Book Online at Low Prices in India | Adjuvant Therapy of Primary Breast Cancer (Recent Results in Cancer Research) Reviews
Pathologic evaluation of response to neoadjuvant therapy drives treatment changes and improves long‐term outcomes for breast cancer patients - Bossuyt - 2020 - The Breast Journal - Wiley Online Library
Risk for breast cancer recurrence as determined by Adjuvant! Online and... | Download Scientific Diagram
36:1%3C1::aid-cncr2820360102%3E3.0.co;2-4.fp.png "The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) - Fisher - 1975 - Cancer - Wiley Online Library")
The pathology of invasive breast cancer A Syllabus Derived from Findings of the National Surgical Adjuvant Breast Project (Protocol No. 4) - Fisher - 1975 - Cancer - Wiley Online Library
Risk Estimations and Treatment Decisions in Early Stage Breast Cancer: Agreement Among Oncologists and the Impact of the 70-Gene Signature - Agendia Inc.
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline - Agendia Inc.
Table of Contents page: Clinical Breast Cancer
Adjuvant S-1 plus endocrine therapy for oestrogen receptor-positive, HER2-negative, primary breast cancer: a multicentre, open-label, randomised, controlled, phase 3 trial - The Lancet Oncology
Prognostic data based on population-based analysis with Adjuvant!... | Download Scientific Diagram
Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer - ScienceDirect
Herceptin® (trastuzumab) Dosing in HER2+ Adjuvant Breast Cancer
